Advertisement

---

PROLOR BIOTECH, INC.

PROLOR Biotech to Present Positive Results From Preclinical Studies of Long-Acting Clotting Factor VIIa-CTP at ISTH 2013

[2013-07-03] - --New Data Show a Simple Subcutaneous Injection of Factor VIIa-CTP Could Potentially Replace Current Therapies Administered Via Infusion--


PROLOR Biotech To Present New Data On Its Long-Acting Human Growth Hormone And Long-Acting Oxyntomodulin At ENDO 2013

[2013-06-13] - -- hGH-CTP and MOD-6030 to be Featured in Oral and Poster Presentations at Endocrine Society's Annual Meeting --


PROLOR Biotech Initiates Pivotal Phase III Trial Of Its Longer-Acting Version Of Human Growth Hormone

[2013-06-04] -


PROLOR Biotech To Present At Jefferies 2013 Global Healthcare Conference

[2013-05-31] -


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers